DLX5 (Distal-less Homeobox 5) Promotes Tumor Cell Proliferation by Transcriptionally Regulating MYC
Jinfei Xu(Fox Chase Cancer Center), Joseph R. Testa(Fox Chase Cancer Center)
Cited by 63
Related Papers
Genetic Dissection of the Oncogenic mTOR Pathway Reveals Druggable Addiction to Translational Control via 4EBP-eIF4E
|Cancer Cell|2010|463
High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas.
|Proceedings of the National Academy of Sciences|1995|365
Protein Kinase B/AKT 1 Plays a Pivotal Role in Insulin-like Growth Factor-1 Receptor Signaling Induced 3T3-L1 Adipocyte Differentiation
|Journal of Biological Chemistry|2004|207
Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome
|Genes Chromosomes and Cancer|2011|107
Upregulation of DLX5 Promotes Ovarian Cancer Cell Proliferation by Enhancing IRS-2-AKT Signaling
|Cancer Research|2010|84